已发表论文

COVID-19 患者的自发性前列腺出血:病例报告

 

Authors Huang J, Ding H, Feng C, Mao D, Tai S

Received 5 March 2023

Accepted for publication 9 May 2023

Published 16 May 2023 Volume 2023:16 Pages 3035—3040

DOI https://doi.org/10.2147/IDR.S410962

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Héctor M Mora-Montes

Abstract: Hematuria occurring in patients with acute kidney injury caused by Corona Virus Disease 2019 (COVID-19) infection has been reported. However, cases of macroscopic hematuria in COVID-19 patients leading to a severe decrease in hemoglobin have not been reported heretofore. Herein, we describe the case of a 56-year-old male patient who suffered from spontaneous prostatic hemorrhage caused by thrombocytopenia and coagulation dysfunction associated with COVID-19 infection, which manifested as macroscopic hematuria, bladder blood clot tamponade and severe hemoglobin decline. Prostatic hemorrhage was diagnosed by endoscopy. There was no recurrence of macroscopic hematuria after undergoing transurethral prostate electrocoagulation for hemostasis, infusing plasma to supplement coagulation factors and taking finasteride. One month after the bleeding event, the patient’s blood routine reexamination revealed that the platelet count returned to the normal value and coagulation was normal.
Keywords: COVID-19, hematuria, prostatic hemorrhage, thrombocytopenia, coagulation dysfunction, bleeding event